Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Everfront Biotech Co., Ltd.

NCT03234595 is registered in ClinicalTrials.gov with Everfront Biotech Co., Ltd. as lead sponsor.

NCT NCT03234595
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03234595 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Everfront Biotech Co., Ltd.
Lead sponsor
Everfront Biotech Co., Ltd.
Phase
Phase 1/2
Overall status
Completed
Start date
November 1, 2017
Completion date
September 3, 2024
Enrollment
22 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent gbm